|
Volumn 30, Issue 4, 1997, Pages 823-851
|
FDA approved? A critique of the artificial insemination industry in the United States.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
ARTIFICIAL INSEMINATION;
CONFIDENTIALITY;
DONOR;
DONOR SELECTION;
GENETIC SCREENING;
GENETICS AND REPRODUCTION;
GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH CARE FACILITY;
HUMAN;
INDUSTRY;
INTERPERSONAL COMMUNICATION;
LEGAL APPROACH;
LEGAL ASPECT;
MALE;
PRACTICE GUIDELINE;
SPERMATOZOON;
STANDARD;
UNITED STATES;
GENETICS AND REPRODUCTION;
LEGAL APPROACH;
CONFIDENTIALITY;
DISCLOSURE;
DONOR SELECTION;
FEDERAL GOVERNMENT;
GENETIC SCREENING;
GOVERNMENT REGULATION;
GUIDELINES;
HUMANS;
INDUSTRY;
INSEMINATION, ARTIFICIAL, HETEROLOGOUS;
MALE;
SPERM BANKS;
SPERMATOZOA;
TISSUE DONORS;
UNITED STATES;
|
EID: 33644951859
PISSN: 0363602X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|